Cargando…

Immune surveillance of pre-cancerous senescent hepatocytes limits hepatocellular carcinoma development

Here we discuss a recently published study from our group on how a continuous CD4 T-cell dependent immune clearance of premalignant senescent cells, designated “senescence surveillance,” restricts liver cancer development.

Detalles Bibliográficos
Autores principales:	Yevsa, Tetyana, Kang, Tae-Won, Zender, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2012
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382854/ https://www.ncbi.nlm.nih.gov/pubmed/22737629 http://dx.doi.org/10.4161/onci.19128

Ejemplares similares

Tricking an ancient immune function to eradicate hepatocellular carcinoma
por: Miyazaki, Toru, et al.
Publicado: (2015)

IRF-1 is critical for IFNγ mediated immune surveillance
por: Ksienzyk, Antje, et al.
Publicado: (2012)

YES, a novel therapeutic target in hepatocellular carcinoma
por: Lapouge, Marjorie, et al.
Publicado: (2022)

KIR/HLA immunogenetic background influences the evolution of hepatocellular carcinoma
por: Cariani, Elisabetta, et al.
Publicado: (2013)

Cisd2 haploinsufficiency: A driving force for hepatocellular carcinoma
por: Shen, Zhao-Qing, et al.
Publicado: (2018)

Tumor growth fueled by spurious senescence phenotypes
por: Mastri, Michalis, et al.
Publicado: (2019)

New control of the senescence barrier in breast cancer
por: Costa, Tânia D. F., et al.
Publicado: (2020)

Cellular senescence enhances adaptive anticancer immunosurveillance
por: Marin, Ines, et al.
Publicado: (2022)

A glypican-3-derived peptide vaccine against hepatocellular carcinoma
por: Sawada, Yu, et al.
Publicado: (2012)

Impact of multiplicity of functional KIR-HLA compound genotypes on hepatocellular carcinoma
por: Tanimine, Naoki, et al.
Publicado: (2015)

Immunosurveillance of senescent cancer cells by natural killer cells
por: Iannello, Alexandre, et al.
Publicado: (2014)

Escape from senescence: revisiting cancer therapeutic strategies
por: Zampetidis, Christos P., et al.
Publicado: (2022)

Senescence drives non-cell autonomous tumorigenesis in the pituitary gland
por: Gonzalez-Meljem, Jose Mario, et al.
Publicado: (2018)

High immunosuppressive burden in advanced hepatocellular carcinoma patients: Can effector functions be restored?
por: Lugade, Amit A, et al.
Publicado: (2013)

Registered report: Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
por: Raouf, Samrrah, et al.
Publicado: (2015)

Adaptive immune resistance in HPV-associated head and neck squamous cell carcinoma
por: Pai, Sara I.
Publicado: (2013)

RON promotes the metastatic spread of breast carcinomas by subverting antitumor immune responses
por: Eyob, Henok, et al.
Publicado: (2013)

Immune-mediated tumor evolution: Nanog links the emergence of a stem like cancer cell state and immune evasion
por: Mao, Chih-Ping, et al.
Publicado: (2014)

The senescence-associated secretory phenotype as a driver of tumor growth: does G3BP1 hold the key?
por: Omer, Amr, et al.
Publicado: (2021)

Extracellular vesicles released by ovarian carcinoma contain arginase 1 that mitigates antitumor immune response
por: Sosnowska, Anna, et al.
Publicado: (2019)

Evasion before invasion: Pre-cancer immunosurveillance
por: Angelova, Mihaela, et al.
Publicado: (2021)

Asparagine, a critical limiting metabolite during glutamine starvation
por: Jiang, Jie, et al.
Publicado: (2018)

Hypoxia-driven immunosuppression contributes to the pre-metastatic niche
por: Sceneay, Jaclyn, et al.
Publicado: (2013)

Pre-surgical oncolytic virotherapy improves breast cancer outcomes
por: Mullins-Dansereau, Victor, et al.
Publicado: (2019)

Targeting HSP90 sensitizes pancreas carcinoma to PD-1 blockade
por: Liu, Jiao, et al.
Publicado: (2022)

Intratumoral alterations of dendritic-cell differentiation and CD8(+) T-cell anergy are immune escape mechanisms of clear cell renal cell carcinoma
por: Noessner, Elfriede, et al.
Publicado: (2012)

The dark side of Toll-like receptor signaling: TLR9 activation limits the efficacy cancer radiotherapy
por: Kortylewski, Marcin, et al.
Publicado: (2014)

Limitations for TCR gene therapy by MHC-restricted fratricide and TCR-mediated hematopoietic stem cell toxicity
por: Schendel, Dolores J., et al.
Publicado: (2013)

Controlling the mitochondrial antisense – role of the SUV3-PNPase complex and its co-factor GRSF1 in mitochondrial RNA surveillance
por: Pietras, Zbigniew, et al.
Publicado: (2018)

Carving out its niche: A role for carbonic anhydrase IX in pre-metastatic niche development
por: Chafe, Shawn C, et al.
Publicado: (2015)

Immune ambivalence: The schizophrenic bleomycin
por: Mignot, Grégoire, et al.
Publicado: (2013)

FOXP3-specific immunity
por: Andersen, Mads Hald
Publicado: (2013)

The ART of tumor immune escape
por: Wennerberg, Erik, et al.
Publicado: (2022)

The aryl hydrocarbon receptor in tumor immunity
por: Platten, Michael, et al.
Publicado: (2012)

Polyamine blockade promotes antitumor immunity
por: Hayes, Candace S, et al.
Publicado: (2014)

Glycan-mediated modification of the immune response
por: Madsen, Caroline B., et al.
Publicado: (2013)

The immune response in HPV(+) oropharyngeal cancer
por: King, Emma V, et al.
Publicado: (2014)

The colorectal cancer immune paradox revisited
por: Angelova, Mihaela, et al.
Publicado: (2015)

Retinoic acid on stage in antitumor immunity
por: Guo, Yanxia, et al.
Publicado: (2013)

Targeting coagulation to unlock antitumor immunity?
por: Galmiche, Antoine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2ecob8v5nfvsp3qqsnu1sisrpm